Supply of Pomalidomide for Belgian healthcare institution.
This tender covers the supply of Pomalidomide, a pharmaceutical product used in the treatment of multiple myeloma. The buyer is a Belgian healthcare institution, likely a hospital or public health authority, serving patients requiring this medication. The contract involves regular deliveries over a defined period, with specific requirements for storage, handling, and quality assurance. Bidders must be authorized pharmaceutical distributors with relevant certifications and experience in supplying controlled substances. The estimated value is not disclosed, but the contract is expected to be of significant scale given the specialized nature of the product.